21 January 2026
QV Bioelectronics secures £4.5m to advance implantable brain cancer therapy into first-in-human studies
QV Bioelectronics has secured £4.5m in investment and grant funding to support the next phase of development of GRACE, its world-first fully implantable electric field…
Interested in Receiving our Press Releases?
Join our Mailing List
{form}